首页 > 最新文献

Iranian Journal of Medical Sciences最新文献

英文 中文
The Impact of the COVID-19 Pandemic on Patients with Breast Cancer, Diagnostic Delays and Disease Progression: A Retrospective Study. COVID-19大流行对乳腺癌患者、诊断延迟和疾病进展的影响:一项回顾性研究
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.30476/ijms.2025.105608.3951
Alireza Rezvani, Reza Heydarzadeh, Reza Golchin Vafa, Sina Sohrabizadeh, Mohammad Hossein Rahmani, Vahid Zangouri, Hossein Molavi Vardanjani, Hourshad Zarifkar, Houman Zarifkar, Houyar Zarifkar, Reza Shahriarirad

Background: Breast cancer is the most frequent malignancy among women. The COVID-19 pandemic significantly impacted healthcare systems, potentially affecting the management of this disease. Due to the critical importance of early diagnosis and treatment, and the limited data on the pandemic's specific effects, this study aimed to determine the correlation between the COVID-19 pandemic and various breast cancer parameters.

Methods: This retrospective study included patients with breast cancer in Shiraz, Iran. Patients were divided into two groups, including those diagnosed before and after the start of the COVID-19 pandemic (from September 2018 to March 2021). Variables included demographic, clinical, and management features. Continuous variables were reported as mean±SD, and the categorical data were reported as frequency and percentage. The significance level was set as P<0.05.

Results: The study documented 1,435 patients: 811 patients were diagnosed before the pandemic, and 624 patients were diagnosed after. The mean initial tumor size at the time of diagnosis was significantly larger in the post-pandemic group than the pre-pandemic group (2.29±1.44 vs. 2.11±1.39 cm, respectively; P=0.001). The distribution of cancer stages also differed significantly (P=0.001). While the prevalence of stage 1 disease was similar between groups (30.1% vs. 28.9%), the prevalence of stage 2 (14.8% vs. 8.5%) and stage 3 (10.1% vs. 7.0%) was significantly higher in the post-pandemic group (Stage 1: 30.1 vs. 28.9%, Stage 2: 8.5 vs. 14.8%, Stage 3: 7 vs. 10.1%; P=0.001).

Conclusion: Following the COVID-19 pandemic, patients presented with significantly larger breast tumors, increased axillary involvement, and more advanced stages after the COVID-19 pandemic.

背景:乳腺癌是女性中最常见的恶性肿瘤。COVID-19大流行严重影响了卫生保健系统,可能影响到这一疾病的管理。由于早期诊断和治疗至关重要,并且关于大流行具体影响的数据有限,本研究旨在确定COVID-19大流行与各种乳腺癌参数之间的相关性。方法:本回顾性研究纳入了伊朗设拉子地区的乳腺癌患者。患者分为两组,包括在COVID-19大流行开始之前和之后(2018年9月至2021年3月)诊断的患者。变量包括人口统计学、临床和管理特征。连续变量以mean±SD报告,分类数据以频率和百分比报告。结果:该研究记录了1435名患者,其中811名患者在大流行之前被诊断出来,624名患者在大流行之后被诊断出来。大流行后组诊断时的平均初始肿瘤大小显著大于大流行前组(分别为2.29±1.44 cm和2.11±1.39 cm, P=0.001)。癌症分期的分布也有显著差异(P=0.001)。虽然各组之间的1期患病率相似(30.1%对28.9%),但大流行后组的2期患病率(14.8%对8.5%)和3期患病率(10.1%对7.0%)明显更高(1期:30.1对28.9%,2期:8.5对14.8%,3期:7对10.1%;P=0.001)。结论:2019冠状病毒病大流行后,患者乳腺肿瘤明显增大,腋窝受累增加,分期更晚。
{"title":"The Impact of the COVID-19 Pandemic on Patients with Breast Cancer, Diagnostic Delays and Disease Progression: A Retrospective Study.","authors":"Alireza Rezvani, Reza Heydarzadeh, Reza Golchin Vafa, Sina Sohrabizadeh, Mohammad Hossein Rahmani, Vahid Zangouri, Hossein Molavi Vardanjani, Hourshad Zarifkar, Houman Zarifkar, Houyar Zarifkar, Reza Shahriarirad","doi":"10.30476/ijms.2025.105608.3951","DOIUrl":"10.30476/ijms.2025.105608.3951","url":null,"abstract":"<p><strong>Background: </strong>Breast cancer is the most frequent malignancy among women. The COVID-19 pandemic significantly impacted healthcare systems, potentially affecting the management of this disease. Due to the critical importance of early diagnosis and treatment, and the limited data on the pandemic's specific effects, this study aimed to determine the correlation between the COVID-19 pandemic and various breast cancer parameters.</p><p><strong>Methods: </strong>This retrospective study included patients with breast cancer in Shiraz, Iran. Patients were divided into two groups, including those diagnosed before and after the start of the COVID-19 pandemic (from September 2018 to March 2021). Variables included demographic, clinical, and management features. Continuous variables were reported as mean±SD, and the categorical data were reported as frequency and percentage. The significance level was set as P<0.05.</p><p><strong>Results: </strong>The study documented 1,435 patients: 811 patients were diagnosed before the pandemic, and 624 patients were diagnosed after. The mean initial tumor size at the time of diagnosis was significantly larger in the post-pandemic group than the pre-pandemic group (2.29±1.44 vs. 2.11±1.39 cm, respectively; P=0.001). The distribution of cancer stages also differed significantly (P=0.001). While the prevalence of stage 1 disease was similar between groups (30.1% vs. 28.9%), the prevalence of stage 2 (14.8% vs. 8.5%) and stage 3 (10.1% vs. 7.0%) was significantly higher in the post-pandemic group (Stage 1: 30.1 vs. 28.9%, Stage 2: 8.5 vs. 14.8%, Stage 3: 7 vs. 10.1%; P=0.001).</p><p><strong>Conclusion: </strong>Following the COVID-19 pandemic, patients presented with significantly larger breast tumors, increased axillary involvement, and more advanced stages after the COVID-19 pandemic.</p>","PeriodicalId":14510,"journal":{"name":"Iranian Journal of Medical Sciences","volume":"51 1","pages":"60-69"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858447/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seeing Clearly, Worrying Less? Patient Psychology and Radiological Anxiety in the Era of Ultra-Low-Dose CT Imaging. 看得清楚,担心得少?超低剂量CT成像时代的患者心理与放射学焦虑。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.30476/ijms.2025.106843.4114
Haewon Byeon

None.

无。
{"title":"Seeing Clearly, Worrying Less? Patient Psychology and Radiological Anxiety in the Era of Ultra-Low-Dose CT Imaging.","authors":"Haewon Byeon","doi":"10.30476/ijms.2025.106843.4114","DOIUrl":"10.30476/ijms.2025.106843.4114","url":null,"abstract":"<p><p>None.</p>","PeriodicalId":14510,"journal":{"name":"Iranian Journal of Medical Sciences","volume":"51 1","pages":"77-80"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858479/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Adverse Effects of Fenugreek in Humans: A Scoping Review. 探索胡芦巴对人类的不良影响:范围综述。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.30476/ijms.2025.106073.4017
Ehsan Amiri Ardekani, Mohammad Mahdi Parvizi, Roghaye Zare, Maryam Mosaffa Jahromi, Thomas Rampp, Mehdi Pasalar

Background: Trigonella foenum-graecum, commonly known as fenugreek, is used both as a spice and a medicinal herb. While numerous studies investigated its therapeutic effects, this scoping review aimed to explore the reported adverse effects associated with fenugreek consumption in humans.

Methods: A systematic search of several scientific databases was conducted, including Google Scholar, Web of Science, PubMed/PMC-MEDLINE, Scopus, and Science Direct, from January 1990 to September 2024. The search utilized keywords such as "Fenugreek", "Adverse Effects", "Clinical Trial", and "Case Report", or "Case Series". References of retrieved articles were also screened.

Results: The review included 60 articles. Of these, 14 clinical trials reported adverse effects, 23 reported none, and 13 did not provide information on adverse effects. Additionally, 10 case reports or case series (reported in eight articles) detailed allergic reactions or hypersensitivity signs and symptoms. The most common adverse effect was mild gastrointestinal discomfort following oral consumption. Other reported effects included hypoglycemia, potential hypokalemia, allergic reactions, a maple syrup odor in the urine, sweat, or skin of infants and mothers, and interactions with certain medications.

Conclusion: Fenugreek is generally considered safe, with most reported side effects being mild and self-limiting. No fatalities have been attributed to its use. This evidence might be valuable for both the general public and healthcare professionals.

背景:葫芦巴(Trigonella foenum-graecum),俗称葫芦巴,既可用作香料,也可用作草药。虽然有许多研究调查了其治疗效果,但本综述旨在探讨报道的胡芦巴食用对人类的不良影响。方法:系统检索谷歌Scholar、Web of Science、PubMed/PMC-MEDLINE、Scopus、Science Direct等科学数据库,检索时间为1990年1月~ 2024年9月。搜索关键词包括“胡芦巴”、“不良反应”、“临床试验”、“病例报告”或“病例系列”。对检索文献的参考文献也进行了筛选。结果:纳入文献60篇。其中,14项临床试验报告了不良反应,23项没有报告,13项没有提供不良反应的信息。此外,10例病例报告或病例系列(8篇文章)详细描述了过敏反应或超敏体征和症状。最常见的不良反应是口服后轻度胃肠道不适。其他报告的影响包括低血糖、潜在的低钾血症、过敏反应、婴儿和母亲的尿液、汗液或皮肤中有枫糖浆气味,以及与某些药物的相互作用。结论:胡芦巴通常被认为是安全的,大多数报道的副作用是轻微的和自限性的。目前还没有人因使用它而死亡。这一证据可能对公众和医疗保健专业人员都有价值。
{"title":"Exploring the Adverse Effects of Fenugreek in Humans: A Scoping Review.","authors":"Ehsan Amiri Ardekani, Mohammad Mahdi Parvizi, Roghaye Zare, Maryam Mosaffa Jahromi, Thomas Rampp, Mehdi Pasalar","doi":"10.30476/ijms.2025.106073.4017","DOIUrl":"10.30476/ijms.2025.106073.4017","url":null,"abstract":"<p><strong>Background: </strong><i>Trigonella foenum-graecum</i>, commonly known as fenugreek, is used both as a spice and a medicinal herb. While numerous studies investigated its therapeutic effects, this scoping review aimed to explore the reported adverse effects associated with fenugreek consumption in humans.</p><p><strong>Methods: </strong>A systematic search of several scientific databases was conducted, including Google Scholar, Web of Science, PubMed/PMC-MEDLINE, Scopus, and Science Direct, from January 1990 to September 2024. The search utilized keywords such as \"Fenugreek\", \"Adverse Effects\", \"Clinical Trial\", and \"Case Report\", or \"Case Series\". References of retrieved articles were also screened.</p><p><strong>Results: </strong>The review included 60 articles. Of these, 14 clinical trials reported adverse effects, 23 reported none, and 13 did not provide information on adverse effects. Additionally, 10 case reports or case series (reported in eight articles) detailed allergic reactions or hypersensitivity signs and symptoms. The most common adverse effect was mild gastrointestinal discomfort following oral consumption. Other reported effects included hypoglycemia, potential hypokalemia, allergic reactions, a maple syrup odor in the urine, sweat, or skin of infants and mothers, and interactions with certain medications.</p><p><strong>Conclusion: </strong>Fenugreek is generally considered safe, with most reported side effects being mild and self-limiting. No fatalities have been attributed to its use. This evidence might be valuable for both the general public and healthcare professionals.</p>","PeriodicalId":14510,"journal":{"name":"Iranian Journal of Medical Sciences","volume":"51 1","pages":"4-18"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858439/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Where Science Meets Devotion: The Lifelong Journey of Professor Mohammad-Reza Panjehshahin. 《科学与奉献:穆罕默德-礼萨·潘杰沙欣教授的一生》
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.30476/ijms.2025.51469
Ahmad Tavakoli, Behrouz Shademan
{"title":"Where Science Meets Devotion: The Lifelong Journey of Professor Mohammad-Reza Panjehshahin.","authors":"Ahmad Tavakoli, Behrouz Shademan","doi":"10.30476/ijms.2025.51469","DOIUrl":"https://doi.org/10.30476/ijms.2025.51469","url":null,"abstract":"","PeriodicalId":14510,"journal":{"name":"Iranian Journal of Medical Sciences","volume":"51 1","pages":"3"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858436/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research Priorities for Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome in Iran: A Mixed-Methods Study Combining a Systematic Review and Delphi Consensus Approach. 伊朗人类免疫缺陷病毒和获得性免疫缺陷综合征的研究重点:一项结合系统评价和德尔菲共识方法的混合方法研究。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.30476/ijms.2025.104577.3819
Forugh Aleebrahim, Marzieh Mahboobi, Fatemeh Rezaee, Maryam Nasirian

Background: In 2022, human immunodeficiency virus (HIV) affected 39 million globally, with Iran experiencing a concentrated epidemic. This study aimed to identify and prioritize critical HIV/AIDS research areas to address existing gaps in the Iranian context.

Methods: Researchers at Isfahan University of Medical Sciences employed a three-phase approach between May 2018 and March 2023. The first phase involved developing an HIV research matrix tailored to international guidelines and the Iranian context. In the second phase, a systematic review of HIV-related studies in Iran was conducted following the PRISMA protocol to assess quality and relevance. The third phase utilized a three-round Delphi method to collect expert feedback, which was used to prioritize research areas based on their importance and feasibility.

Results: A systematic review of 6,310 sources yielded 745 documents for full-text analysis. Key research domains identified included prevention, diagnosis, care and treatment, epidemiology, and co-infections. Quantitative analysis indicated that 23% of studies focused on co-infections, while ethical issues were addressed in only 0.04%. Qualitative assessment revealed that 54% of reviewed studies were of low quality. Subsequent expert consultation and multi-criteria decision analysis ranked laboratory research and co-infections as the highest priorities. Specific sub-areas identified included molecular epidemiology and interventions addressing stigma and discrimination. Despite being highly cost-effective and urgently needed, research on stigma-related interventions exhibited a significant gap.

Conclusion: The study identified 11 main research areas and 60 sub-areas as priorities for HIV/AIDS research in Iran, highlighting the need for strategic funding and research planning. Ethical considerations and laboratory improvements are essential for enhancing public health outcomes and addressing emerging challenges in the HIV epidemic.

背景:2022年,人类免疫缺陷病毒(HIV)在全球影响了3900万人,其中伊朗经历了一次集中流行。这项研究旨在确定和优先考虑关键的艾滋病毒/艾滋病研究领域,以解决伊朗背景下现有的差距。方法:伊斯法罕医学科学大学的研究人员在2018年5月至2023年3月期间采用了三阶段方法。第一阶段是根据国际准则和伊朗的情况制定艾滋病毒研究矩阵。在第二阶段,根据PRISMA协议对伊朗的艾滋病毒相关研究进行了系统审查,以评估质量和相关性。第三阶段采用三轮德尔菲法收集专家反馈,根据重要性和可行性对研究领域进行排序。结果:对6310个来源进行系统审查,产生745份全文分析文件。确定的重点研究领域包括预防、诊断、护理和治疗、流行病学和合并感染。定量分析表明,23%的研究集中在合并感染上,而伦理问题仅占0.04%。定性评估显示,54%的综述研究质量较低。随后的专家咨询和多标准决策分析将实验室研究和合并感染列为最高优先事项。确定的具体分领域包括分子流行病学和解决耻辱和歧视的干预措施。尽管与耻辱相关的干预措施具有很高的成本效益和迫切的需求,但研究显示出很大的差距。结论:该研究确定了伊朗艾滋病毒/艾滋病研究的11个主要研究领域和60个子领域,强调了战略资助和研究规划的必要性。伦理考虑和实验室改进对于加强公共卫生成果和应对艾滋病毒流行病中新出现的挑战至关重要。
{"title":"Research Priorities for Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome in Iran: A Mixed-Methods Study Combining a Systematic Review and Delphi Consensus Approach.","authors":"Forugh Aleebrahim, Marzieh Mahboobi, Fatemeh Rezaee, Maryam Nasirian","doi":"10.30476/ijms.2025.104577.3819","DOIUrl":"10.30476/ijms.2025.104577.3819","url":null,"abstract":"<p><strong>Background: </strong>In 2022, human immunodeficiency virus (HIV) affected 39 million globally, with Iran experiencing a concentrated epidemic. This study aimed to identify and prioritize critical HIV/AIDS research areas to address existing gaps in the Iranian context.</p><p><strong>Methods: </strong>Researchers at Isfahan University of Medical Sciences employed a three-phase approach between May 2018 and March 2023. The first phase involved developing an HIV research matrix tailored to international guidelines and the Iranian context. In the second phase, a systematic review of HIV-related studies in Iran was conducted following the PRISMA protocol to assess quality and relevance. The third phase utilized a three-round Delphi method to collect expert feedback, which was used to prioritize research areas based on their importance and feasibility.</p><p><strong>Results: </strong>A systematic review of 6,310 sources yielded 745 documents for full-text analysis. Key research domains identified included prevention, diagnosis, care and treatment, epidemiology, and co-infections. Quantitative analysis indicated that 23% of studies focused on co-infections, while ethical issues were addressed in only 0.04%. Qualitative assessment revealed that 54% of reviewed studies were of low quality. Subsequent expert consultation and multi-criteria decision analysis ranked laboratory research and co-infections as the highest priorities. Specific sub-areas identified included molecular epidemiology and interventions addressing stigma and discrimination. Despite being highly cost-effective and urgently needed, research on stigma-related interventions exhibited a significant gap.</p><p><strong>Conclusion: </strong>The study identified 11 main research areas and 60 sub-areas as priorities for HIV/AIDS research in Iran, highlighting the need for strategic funding and research planning. Ethical considerations and laboratory improvements are essential for enhancing public health outcomes and addressing emerging challenges in the HIV epidemic.</p>","PeriodicalId":14510,"journal":{"name":"Iranian Journal of Medical Sciences","volume":"51 1","pages":"19-31"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858440/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Risk Factors of Alcohol, Tobacco, and Substance Use among Medical Students in Southern Iran in 2024: A Growing Concern. 2024年伊朗南部医学生中酒精、烟草和物质使用的患病率和危险因素:一个日益关注的问题。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.30476/ijms.2025.105529.3935
Seyed Ali Mansouri, Alireza Salehi, Masih Sedigh Ardekani, Dorsa Shekouh

Background: Alcohol, smoking, and substance use among medical students are significant health concerns that impact their well-being and their future roles as health advocates. This study aimed to investigate the prevalence of these behaviors and related risk factors among medical students in southern Iran.

Methods: This cross-sectional study was conducted among medical students in Shiraz, in southern Iran, in 2024. Data were collected using the World Health Organization's alcohol, smoking, and substance involvement screening test (ASSIST), supplemented with questions on demographic details, family and friend substance use, mental health, and major satisfaction. The sample was selected using the stratified random selection method. Logistic regression models were used to identify factors associated with substance use, controlling for potential confounders. P<0.05 was considered statistically significant. All analyses were performed using SPSS software (version 26, SPSS Inc., USA).

Results: The study included 360 medical students, of whom 51.9% were men, with a mean age of 22.62±3.02 years. The lifetime prevalence was 27.5% for alcoholic beverages, 26.7% for tobacco products, 14.4% for sedatives or sleeping pills, and 15.8% for electronic cigarettes and vapes. Logistic regressions analysis revealed that having a family member who uses substances (OR=1.8, 95% CI: 1.01-3.5), having a friend who uses substances (OR=3.9, 95% CI: 2.0-7.8), being male (OR=1.8, 95% CI: 1.03-3.2), and having a recent history of mental illnesses (OR=2.8, 95% CI: 1.1-7.1) were positively associated with lifetime cigarette use.

Conclusion: The prevalence of alcohol, smoking, and substance use among medical students in southern Iran is concerning. These findings emphasized the significance of targeted interventions to reduce and prevent use within this population.

背景:医学生中的酒精、吸烟和药物使用是影响他们健康和未来健康倡导者角色的重要健康问题。本研究旨在调查这些行为在伊朗南部医学生中的流行程度及相关危险因素。方法:这项横断面研究于2024年在伊朗南部设拉子的医科学生中进行。使用世界卫生组织的酒精、吸烟和物质介入筛查试验(ASSIST)收集数据,并补充有关人口统计细节、家人和朋友物质使用、心理健康和主要满意度的问题。样本选择采用分层随机选择方法。使用逻辑回归模型确定与药物使用相关的因素,控制潜在的混杂因素。结果:共纳入医学生360人,其中男性占51.9%,平均年龄22.62±3.02岁。酒精饮料的终生患病率为27.5%,烟草产品为26.7%,镇静剂或安眠药为14.4%,电子烟和电子烟为15.8%。Logistic回归分析显示,有家庭成员使用药物(OR=1.8, 95% CI: 1.01-3.5)、有朋友使用药物(OR=3.9, 95% CI: 2.0-7.8)、男性(OR=1.8, 95% CI: 1.03-3.2)、近期有精神病史(OR=2.8, 95% CI: 1.1-7.1)与终生吸烟呈正相关。结论:伊朗南部医学生中酒精、吸烟和药物使用的流行情况令人担忧。这些发现强调了有针对性的干预措施在这一人群中减少和预防使用的重要性。
{"title":"Prevalence and Risk Factors of Alcohol, Tobacco, and Substance Use among Medical Students in Southern Iran in 2024: A Growing Concern.","authors":"Seyed Ali Mansouri, Alireza Salehi, Masih Sedigh Ardekani, Dorsa Shekouh","doi":"10.30476/ijms.2025.105529.3935","DOIUrl":"10.30476/ijms.2025.105529.3935","url":null,"abstract":"<p><strong>Background: </strong>Alcohol, smoking, and substance use among medical students are significant health concerns that impact their well-being and their future roles as health advocates. This study aimed to investigate the prevalence of these behaviors and related risk factors among medical students in southern Iran.</p><p><strong>Methods: </strong>This cross-sectional study was conducted among medical students in Shiraz, in southern Iran, in 2024. Data were collected using the World Health Organization's alcohol, smoking, and substance involvement screening test (ASSIST), supplemented with questions on demographic details, family and friend substance use, mental health, and major satisfaction. The sample was selected using the stratified random selection method. Logistic regression models were used to identify factors associated with substance use, controlling for potential confounders. P<0.05 was considered statistically significant. All analyses were performed using SPSS software (version 26, SPSS Inc., USA).</p><p><strong>Results: </strong>The study included 360 medical students, of whom 51.9% were men, with a mean age of 22.62±3.02 years. The lifetime prevalence was 27.5% for alcoholic beverages, 26.7% for tobacco products, 14.4% for sedatives or sleeping pills, and 15.8% for electronic cigarettes and vapes. Logistic regressions analysis revealed that having a family member who uses substances (OR=1.8, 95% CI: 1.01-3.5), having a friend who uses substances (OR=3.9, 95% CI: 2.0-7.8), being male (OR=1.8, 95% CI: 1.03-3.2), and having a recent history of mental illnesses (OR=2.8, 95% CI: 1.1-7.1) were positively associated with lifetime cigarette use.</p><p><strong>Conclusion: </strong>The prevalence of alcohol, smoking, and substance use among medical students in southern Iran is concerning. These findings emphasized the significance of targeted interventions to reduce and prevent use within this population.</p>","PeriodicalId":14510,"journal":{"name":"Iranian Journal of Medical Sciences","volume":"51 1","pages":"47-59"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858477/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrosternal Burning and Its Endoscopic Associations: Findings from 5,561 Upper Gastrointestinal Endoscopies. 胸骨后烧灼及其内窥镜相关性:5,561例上消化道内窥镜检查结果。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.30476/ijms.2025.105856.4012
Saleh Azadbakht, Saleheh Azadbakht, Narges Naderi, Morteza Azadbakht, Bardia Amidi

Background: Retrosternal burning is often linked to gastroesophageal reflux disease. However, it can also indicate other gastrointestinal disorders. This study aimed to compare and assess upper gastrointestinal (UGI) endoscopic findings in patients with and without retrosternal burning to determine its clinical significance.

Methods: This cross-sectional study analyzed data from 5,561 patients who underwent UGI endoscopy in Khorramabad, Iran (2018-2023). Required data, such as demographics, clinical symptoms, and endoscopic diagnoses, including the grade and severity of esophagitis and sliding hiatal hernia, were collected and compared. Statistical significance was set at P<0.05.

Results: Of the patients, 57.08% were women. The most common indications for endoscopy were dyspepsia and retrosternal burning. Sliding hiatal hernia (49.73%), esophagitis (60.04%), and antral gastropathy (76.53%) were the most frequent endoscopic findings. Grade 2 was the most prevalent type in patients with hernias (74.80%), and among patients with esophagitis, Grade A was predominant (87.36%). Retrosternal burning showed a significant positive association with sliding hiatal hernia, esophagitis, gastric antral gastropathy, and inlet patches (P<0.001). In contrast, the absence of retrosternal burning was associated with gastric ulcers, gastric and esophageal masses (P<0.001), duodenal ulcers (P=0.037), and bulb deformities (P=0.015). A significant association was found between retrosternal burning and the severity of both sliding hiatal hernia and esophagitis (P<0.001).

Conclusion: Retrosternal burning was frequently observed in patients with certain UGI structural abnormalities, such as sliding hiatal hernia and esophagitis, suggesting a possible association. Based on the findings of the present study, a more comprehensive diagnostic approach might be warranted for patients presenting with retrosternal burning to evaluate them for potential structural abnormalities.

背景:胸骨后烧灼常与胃食管反流病有关。然而,它也可以提示其他胃肠道疾病。本研究旨在比较和评估胸骨后烧灼患者和非胸骨后烧灼患者的上消化道(UGI)内镜表现,以确定其临床意义。方法:本横断面研究分析了2018-2023年伊朗霍拉马巴德5561例UGI内窥镜检查患者的数据。收集和比较所需的数据,如人口统计学、临床症状和内镜诊断,包括食管炎和滑脱裂孔疝的等级和严重程度。结果:女性占57.08%。内窥镜检查最常见的适应症是消化不良和胸骨后烧灼。滑动裂孔疝(49.73%)、食管炎(60.04%)和胃窦病(76.53%)是最常见的内镜表现。疝患者中2级发生率最高(74.80%),食管炎患者中A级发生率最高(87.36%)。胸骨后烧灼与滑脱性裂孔疝、食管炎、胃窦胃病、胃入口补片呈显著正相关(p)。结论:在某些UGI结构异常的患者中,如滑脱性裂孔疝、食管炎,经常观察到胸骨后烧灼,提示可能存在相关性。基于本研究的发现,对于出现胸骨后烧灼的患者,可能需要更全面的诊断方法来评估其潜在的结构异常。
{"title":"Retrosternal Burning and Its Endoscopic Associations: Findings from 5,561 Upper Gastrointestinal Endoscopies.","authors":"Saleh Azadbakht, Saleheh Azadbakht, Narges Naderi, Morteza Azadbakht, Bardia Amidi","doi":"10.30476/ijms.2025.105856.4012","DOIUrl":"10.30476/ijms.2025.105856.4012","url":null,"abstract":"<p><strong>Background: </strong>Retrosternal burning is often linked to gastroesophageal reflux disease. However, it can also indicate other gastrointestinal disorders. This study aimed to compare and assess upper gastrointestinal (UGI) endoscopic findings in patients with and without retrosternal burning to determine its clinical significance.</p><p><strong>Methods: </strong>This cross-sectional study analyzed data from 5,561 patients who underwent UGI endoscopy in Khorramabad, Iran (2018-2023). Required data, such as demographics, clinical symptoms, and endoscopic diagnoses, including the grade and severity of esophagitis and sliding hiatal hernia, were collected and compared. Statistical significance was set at P<0.05.</p><p><strong>Results: </strong>Of the patients, 57.08% were women. The most common indications for endoscopy were dyspepsia and retrosternal burning. Sliding hiatal hernia (49.73%), esophagitis (60.04%), and antral gastropathy (76.53%) were the most frequent endoscopic findings. Grade 2 was the most prevalent type in patients with hernias (74.80%), and among patients with esophagitis, Grade A was predominant (87.36%). Retrosternal burning showed a significant positive association with sliding hiatal hernia, esophagitis, gastric antral gastropathy, and inlet patches (P<0.001). In contrast, the absence of retrosternal burning was associated with gastric ulcers, gastric and esophageal masses (P<0.001), duodenal ulcers (P=0.037), and bulb deformities (P=0.015). A significant association was found between retrosternal burning and the severity of both sliding hiatal hernia and esophagitis (P<0.001).</p><p><strong>Conclusion: </strong>Retrosternal burning was frequently observed in patients with certain UGI structural abnormalities, such as sliding hiatal hernia and esophagitis, suggesting a possible association. Based on the findings of the present study, a more comprehensive diagnostic approach might be warranted for patients presenting with retrosternal burning to evaluate them for potential structural abnormalities.</p>","PeriodicalId":14510,"journal":{"name":"Iranian Journal of Medical Sciences","volume":"51 1","pages":"32-38"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858433/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Probiotics Outperform Antioxidants in Improving Semen Parameters of Men with Idiopathic Oligoasthenoteratozoospermia: A Randomized Controlled Trial. 在改善特发性少弱无畸形精子症男性精液参数方面,益生菌优于抗氧化剂:一项随机对照试验
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.30476/ijms.2025.105150.3888
Farshad Gholipour, Davoud Gharakhani, Amirhossein Rahavian, Mahdi Norouzi, Mohammadreza Hajian, Serajoddin Vahidi, Mohammad Javad Nazarpour, Farbod Khorrami

Background: Idiopathic oligoasthenoteratozoospermia (iOAT) treatment still poses significant challenges. This study aims to compare the therapeutic efficacy of probiotics on sperm parameters of iOAT patients with placebo and antioxidants.

Methods: In this triple-blind, randomized controlled trial, 110 men with iOAT were assigned to receive either a probiotic (Familact®), an antioxidant (Sperigen®), or a placebo daily for 3 months, in two academic centers in Iran (Isfahan and Yazd). The study was conducted from July 2021 to April 2022. Sperm parameters were analyzed using computer-assisted semen analysis. The main measured outcomes included semen volume and sperm features, including motility, morphology, and concentration. Changes in semen parameters were assessed using linear mixed-effects models with fixed effects for time, group, and their interaction. Estimated marginal means were compared across groups using Bonferroni-adjusted pairwise tests.

Results: Overall, 110 men (mean age of 34.3±4.5 years) were included in the final analysis. Significant Time×Group interactions were found for sperm concentration (P=0.003), motility (P<0.001), and morphology (P<0.001), but not for semen volume (P=0.71). After 3 months, the probiotic group showed significantly greater improvements in sperm concentration (10.42±1.11×106/mL, P=0.007), motility (46.65±3.73%, P=0.001), and morphology (4.31±0.21%, P<0.001) compared to the placebo group. Additionally, probiotics outperformed antioxidants in morphology (P<0.001) and motility (P=0.009).

Conclusion: This study is the first to directly compare probiotics and antioxidants in treating iOAT. Probiotics showed superior performance in sperm motility and morphology compared to antioxidants, although drawing a strong conclusion requires further robust studiesTrial Registration Number: IRCT20150420021869N5.

背景:特发性少弱无畸形精子症(iOAT)的治疗仍然面临重大挑战。本研究旨在比较益生菌与安慰剂和抗氧化剂对iOAT患者精子参数的治疗效果。方法:在这项三盲、随机对照试验中,110名患有iOAT的男性在伊朗的两个学术中心(伊斯法罕和亚兹德)每天接受益生菌(Familact®)、抗氧化剂(Sperigen®)或安慰剂,持续3个月。该研究于2021年7月至2022年4月进行。使用计算机辅助精液分析分析精子参数。主要测量结果包括精液量和精子特征,包括活力、形态和浓度。使用线性混合效应模型评估精液参数的变化,该模型对时间、组及其相互作用具有固定效应。使用bonferroni校正两两检验比较各组间估计的边际均值。结果:总共有110名男性(平均年龄34.3±4.5岁)纳入最终分析。精子浓度(P=0.003)、活力(P6/mL, P=0.007)、活力(46.65±3.73%,P=0.001)、形态(4.31±0.21%)与抗氧化剂(P= 0.001)之间存在Time×Group显著交互作用。结论:本研究首次直接比较益生菌与抗氧化剂治疗iOAT的效果。与抗氧化剂相比,益生菌在精子活力和形态方面表现出优越的性能,尽管得出强有力的结论需要进一步的强有力的研究。
{"title":"Probiotics Outperform Antioxidants in Improving Semen Parameters of Men with Idiopathic Oligoasthenoteratozoospermia: A Randomized Controlled Trial.","authors":"Farshad Gholipour, Davoud Gharakhani, Amirhossein Rahavian, Mahdi Norouzi, Mohammadreza Hajian, Serajoddin Vahidi, Mohammad Javad Nazarpour, Farbod Khorrami","doi":"10.30476/ijms.2025.105150.3888","DOIUrl":"10.30476/ijms.2025.105150.3888","url":null,"abstract":"<p><strong>Background: </strong>Idiopathic oligoasthenoteratozoospermia (iOAT) treatment still poses significant challenges. This study aims to compare the therapeutic efficacy of probiotics on sperm parameters of iOAT patients with placebo and antioxidants.</p><p><strong>Methods: </strong>In this triple-blind, randomized controlled trial, 110 men with iOAT were assigned to receive either a probiotic (Familact<sup>®</sup>), an antioxidant (Sperigen<sup>®</sup>), or a placebo daily for 3 months, in two academic centers in Iran (Isfahan and Yazd). The study was conducted from July 2021 to April 2022. Sperm parameters were analyzed using computer-assisted semen analysis. The main measured outcomes included semen volume and sperm features, including motility, morphology, and concentration. Changes in semen parameters were assessed using linear mixed-effects models with fixed effects for time, group, and their interaction. Estimated marginal means were compared across groups using Bonferroni-adjusted pairwise tests.</p><p><strong>Results: </strong>Overall, 110 men (mean age of 34.3±4.5 years) were included in the final analysis. Significant Time×Group interactions were found for sperm concentration (P=0.003), motility (P<0.001), and morphology (P<0.001), but not for semen volume (P=0.71). After 3 months, the probiotic group showed significantly greater improvements in sperm concentration (10.42±1.11×10<sup>6</sup>/mL, P=0.007), motility (46.65±3.73%, P=0.001), and morphology (4.31±0.21%, P<0.001) compared to the placebo group. Additionally, probiotics outperformed antioxidants in morphology (P<0.001) and motility (P=0.009).</p><p><strong>Conclusion: </strong>This study is the first to directly compare probiotics and antioxidants in treating iOAT. Probiotics showed superior performance in sperm motility and morphology compared to antioxidants, although drawing a strong conclusion requires further robust studies<b>Trial Registration Number:</b> IRCT20150420021869N5.</p>","PeriodicalId":14510,"journal":{"name":"Iranian Journal of Medical Sciences","volume":"51 1","pages":"39-46"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858446/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel AP4M1 Variant in an Iranian Child with Spastic Paraplegia 50: A Case Report and Molecular Docking Approach. 一种新的AP4M1变异在伊朗儿童痉挛性截瘫50:一个病例报告和分子对接方法。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.30476/ijms.2025.106981.4128
Hamed Esmaeil Lashgarian, Masumeh Jalalvand, Maryam Zand, Amirmasoud Jalalvand, Leila Abkhooie, Fatemeh Kazemisafa, Hamidreza Khodadadi

Spastic paraplegia 50 (SPG50) is a rare autosomal recessive disorder caused by mutations in the AP4M1 gene (OMIM 602296). It is characterized by spasticity, severe intellectual disability, and delayed or absent speech. The present study reported a case from consanguineous parents, where the affected child presented with intellectual disability, seizures, muscle weakness, and deep white matter hyperintensity. Whole exome sequencing (WES) of the proband identified a novel, homozygous frameshift variant, c.258delG:p.A87Pfs*44, in the AP4M1 gene, which was confirmed by Sanger sequencing. This variant is predicted to cause a large truncation of the protein, leading to a loss of function. Molecular modeling and docking analyses further revealed that the loss of a substantial protein segment disrupts proper intramolecular interactions. A review of the literature on Iranian families with SPG50 yielded few reports, consistent with the disease's rarity. This study expanded the knowledge of the clinical and genetic features of SPG50 and underscored the importance of this variant for genetic diagnosis and counseling in affected families.

痉挛性截瘫50 (SPG50)是一种罕见的常染色体隐性遗传病,由AP4M1基因(OMIM 602296)突变引起。它的特点是痉挛,严重的智力残疾,语言迟缓或缺失。本研究报告了一个来自近亲父母的病例,其中受影响的孩子表现为智力残疾,癫痫发作,肌肉无力和深部白质高强度。先证者的全外显子组测序(WES)鉴定出一种新的纯合子移码变异c.258delG:p。A87Pfs*44,在AP4M1基因中,经Sanger测序证实。据预测,这种变异会导致蛋白质的大量截短,导致功能丧失。分子模型和对接分析进一步表明,大量蛋白质片段的丢失破坏了分子内正常的相互作用。对患有SPG50的伊朗家庭的文献回顾几乎没有报道,这与该病的罕见性相一致。本研究扩大了对SPG50的临床和遗传特征的认识,并强调了该变异对患病家庭的遗传诊断和咨询的重要性。
{"title":"A Novel <i>AP4M1</i> Variant in an Iranian Child with Spastic Paraplegia 50: A Case Report and Molecular Docking Approach.","authors":"Hamed Esmaeil Lashgarian, Masumeh Jalalvand, Maryam Zand, Amirmasoud Jalalvand, Leila Abkhooie, Fatemeh Kazemisafa, Hamidreza Khodadadi","doi":"10.30476/ijms.2025.106981.4128","DOIUrl":"10.30476/ijms.2025.106981.4128","url":null,"abstract":"<p><p>Spastic paraplegia 50 (SPG50) is a rare autosomal recessive disorder caused by mutations in the <i>AP4M1</i> gene (OMIM 602296). It is characterized by spasticity, severe intellectual disability, and delayed or absent speech. The present study reported a case from consanguineous parents, where the affected child presented with intellectual disability, seizures, muscle weakness, and deep white matter hyperintensity. Whole exome sequencing (WES) of the proband identified a novel, homozygous frameshift variant, c.258delG:p.A87Pfs*44, in the <i>AP4M1</i> gene, which was confirmed by Sanger sequencing. This variant is predicted to cause a large truncation of the protein, leading to a loss of function. Molecular modeling and docking analyses further revealed that the loss of a substantial protein segment disrupts proper intramolecular interactions. A review of the literature on Iranian families with SPG50 yielded few reports, consistent with the disease's rarity. This study expanded the knowledge of the clinical and genetic features of SPG50 and underscored the importance of this variant for genetic diagnosis and counseling in affected families.</p>","PeriodicalId":14510,"journal":{"name":"Iranian Journal of Medical Sciences","volume":"51 1","pages":"70-76"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858432/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HIV Research Priorities in Iran: Reflections from the Early Years to a New Framework for Action. 伊朗艾滋病毒研究重点:从早期到新的行动框架的反思。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.30476/ijms.2025.51468
Shohreh Beheshti
{"title":"HIV Research Priorities in Iran: Reflections from the Early Years to a New Framework for Action.","authors":"Shohreh Beheshti","doi":"10.30476/ijms.2025.51468","DOIUrl":"10.30476/ijms.2025.51468","url":null,"abstract":"","PeriodicalId":14510,"journal":{"name":"Iranian Journal of Medical Sciences","volume":"51 1","pages":"1-2"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858442/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Iranian Journal of Medical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1